论文信息 - Integrated safety analysis of the poly (ADP-ribose) polymerase (PARP) inhibitor rucaparib in patients (pts) with ovarian cancer in the treatment and maintenance settings - 字舞流文

Integrated safety analysis of the poly (ADP-ribose) polymerase (PARP) inhibitor rucaparib in patients (pts) with ovarian cancer in the treatment and maintenance settings

A. Tinker | A. Oza | J. Ledermann | E. Swisher | I. McNeish | O. Trédan | R. Coleman | C. Aghajanian | A. Leary | G. Konecny | S. Goble | R. Shapira-Frommer | R. Kristeleit | A. Oaknin | J. Weberpals | D. O’Malley | D. Lorusso | L. Maloney | J. Weberpals | T. Cameron